Berenberg Bank upgraded shares of Spire Healthcare Group (LON:SPI) to a buy rating in a report published on Wednesday, MarketBeat.com reports. The firm currently has GBX 310 ($4.15) price target on the stock, up from their prior price target of GBX 270 ($3.62).
Other research analysts have also recently issued reports about the company. Numis Securities restated an add rating and set a GBX 341 ($4.57) price target on shares of Spire Healthcare Group in a research note on Monday, October 23rd. Liberum Capital restated a hold rating and set a GBX 270 ($3.62) price target on shares of Spire Healthcare Group in a research note on Thursday, November 16th. Jefferies Group decreased their price target on Spire Healthcare Group from GBX 350 ($4.69) to GBX 259 ($3.47) and set a hold rating on the stock in a research note on Monday, September 25th. Finally, J P Morgan Chase & Co decreased their price target on Spire Healthcare Group from GBX 376 ($5.04) to GBX 339 ($4.54) and set a neutral rating on the stock in a research note on Friday, September 15th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of GBX 309.86 ($4.15).
Spire Healthcare Group (LON:SPI) opened at GBX 244.26 ($3.27) on Wednesday. Spire Healthcare Group has a 52 week low of GBX 218.20 ($2.92) and a 52 week high of GBX 362.10 ($4.85).
The business also recently disclosed a dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Thursday, November 16th will be paid a GBX 1.30 ($0.02) dividend. This represents a dividend yield of 0.5%. The ex-dividend date is Thursday, November 16th.
In related news, insider Peter R. Bamford acquired 5,000 shares of Spire Healthcare Group stock in a transaction dated Monday, November 27th. The shares were acquired at an average cost of GBX 240 ($3.21) per share, for a total transaction of £12,000 ($16,070.71). Also, insider Justin Ash acquired 84,500 shares of Spire Healthcare Group stock in a transaction dated Thursday, November 23rd. The stock was bought at an average price of GBX 237 ($3.17) per share, for a total transaction of £200,265 ($268,200.08). Over the last quarter, insiders bought 178,600 shares of company stock worth $41,184,900.
TRADEMARK VIOLATION NOTICE: “Spire Healthcare Group (SPI) Stock Rating Upgraded by Berenberg Bank” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.com-unik.info/2017/12/03/spire-healthcare-group-spi-stock-rating-upgraded-by-berenberg-bank.html.
About Spire Healthcare Group
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
What are top analysts saying about Spire Healthcare Group Plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Spire Healthcare Group Plc and related companies.